William Walsh
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
-
- DNA Repair Mechanisms
- Cell death mechanisms and regulation
Papers in
-
- Lung Cancer Diagnosis and Treatment 4
- Prostate Cancer Treatment and Research 3
- Lung Cancer Treatments and Mutations 1
-
- Acute Myeloid Leukemia Research 1
- Co-authors
- Beverly Plunkett (1 shared paper)Steven J. Kuerbitz (1 shared paper)Michael B. Kastan (1 shared paper)Elliott F. Winton (1 shared paper)Srđan Verstovšek (1 shared paper)Ekatherine Asatiani (1 shared paper)Khaled El‐Shami (1 shared paper)Sameer Ashok Parikh (1 shared paper)
- Journals
- Blood (2 papers)Lung Cancer (2 papers)Frontiers in Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Molecular Cytogenetics (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
William Walsh
20 papers receiving 1.8k citations
William Walsh's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 618
- Molecular Biology 303
- Genetics 41
- Otorhinolaryngology 26
- Cancer Research 48
Countries citing papers authored by William Walsh
This map shows the geographic impact of William Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Walsh more than expected).
Fields of papers citing papers by William Walsh
This network shows the impact of papers produced by William Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Walsh. The network helps show where William Walsh may publish in the future.
Co-authors
The 25 scholars most cited alongside William Walsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Hit paper breakdown → | 1992 | 1591 |
| 2 | 2010 | 80 | |
| 3 | 2018 | 25 | |
| 4 | 2006 | 22 | |
| 5 | 2018 | 21 | |
| 6 | 2007 | 20 | |
| 7 | 2016 | 11 | |
| 8 | 2020 | 10 | |
| 9 | 2013 | 9 | |
| 10 | 2021 | 9 | |
| 11 | 2004 | 8 | |
| 12 | 2018 | 8 | |
| 13 | 2007 | 6 | |
| 14 | 2018 | 6 | |
| 15 | 2023 | 3 | |
| 16 | 2010 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2000 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2021 | 1 |
About William Walsh
William Walsh is a scholar working on Pulmonary and Respiratory Medicine, Hematology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (4 papers), Prostate Cancer Treatment and Research (3 papers), Lung Cancer Treatments and Mutations (1 paper), Telemedicine and Telehealth Implementation (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Acute Myeloid Leukemia Research (1 paper), Cancer-related Molecular Pathways (1 paper) and Esophageal Cancer Research and Treatment (1 paper). The work is most often cited by research in Oncology (618 citations), Molecular Biology (303 citations), Genetics (41 citations), Otorhinolaryngology (26 citations) and Cancer Research (48 citations). William Walsh has collaborated with scholars based in United States and Canada. Frequent co-authors include Beverly Plunkett, Steven J. Kuerbitz, Michael B. Kastan, Elliott F. Winton, Srđan Verstovšek, Ekatherine Asatiani, Khaled El‐Shami, Sameer Ashok Parikh, Aaron David Schimmer and Hagop M. Kantarjian. Their work appears in journals such as Blood, Lung Cancer, Frontiers in Oncology, Journal for ImmunoTherapy of Cancer and Molecular Cytogenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.